FCMC
GILD icon

Founders Capital Management (Connecticut)’s Gilead Sciences GILD Stock Holding History

Founders Capital Management (Connecticut)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-17,777
Closed -$1.21M – 56
2017
Q1 		$1.21M Sell
17,777
-310
-2% -$21.8K 0.62% 31
2016
Q4 		$1.29M Buy
18,087
+21
+0.1% +$1.56K 0.7% 31
2016
Q3 		$1.43M Sell
18,066
-1,850
-9% -$150K 0.8% 31
2016
Q2 		$1.66M Hold
19,916
– – 0.93% 29
2016
Q1 		$1.83M Buy
19,916
+801
+4% +$72.2K 1.06% 27
2015
Q4 		$1.93M Buy
19,115
+50
+0.3% +$5.2K 1.16% 28
2015
Q3 		$1.87M Sell
19,065
-310
-2% -$34.4K 1.21% 27
2015
Q2 		$2.27M Buy
19,375
+430
+2% +$47K 1.36% 22
2015
Q1 		$1.86M Buy
18,945
+1,385
+8% +$141K 1.11% 26
2014
Q4 		$1.66M Buy
17,560
+2,890
+20% +$299K 1.01% 29
2014
Q3 		$1.56M Buy
14,670
+1,110
+8% +$109K 1% 29
2014
Q2 		$1.12M Buy
+13,560
New +$1.06M 0.74% 34

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Founders Capital Management (Connecticut)'s GILD Position: Q2 2017 in Review

Founders Capital Management (Connecticut) sold out of Gilead Sciences (GILD) in Q2 2017, closing a stake of 17,777 shares — an estimated $1.21M sold.

Founders Capital Management (Connecticut) first reported a position in GILD in Q2 2014 and held it in 12 quarters. The position peaked at $2.27M in Q2 2015. 1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • Founders Capital Management (Connecticut) reported no remaining Gilead Sciences position as of Q2 2017 after selling out during the quarter.
  • Founders Capital Management (Connecticut) sold 17,777 Gilead Sciences shares in Q2 2017, an estimated $1.21M.
  • Founders Capital Management (Connecticut) first reported a position in Gilead Sciences in Q2 2014 and held it in 12 quarters.
  • Founders Capital Management (Connecticut)'s Gilead Sciences position peaked at $2.27M in Q2 2015.
  • 1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Founders Capital Management (Connecticut)'s 13F filing for Q2 2017, filed 20 Jul 2017.